MANNKIND CORP Restricted Cash, Current
MANNKIND CORP (MNKD) had Restricted Cash, Current of $158.00 thousand as of 2021-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashCurrent · last filed 2022-05-05
- 2021-03-31: Restricted Cash, Current $158.00K.
- 2020-12-31: Restricted Cash, Current $158.00K.
- 2020-09-30: Restricted Cash, Current $316.00K.
- 2020-06-30: Restricted Cash, Current $316.00K.
| Period end | Restricted Cash, Current |
|---|---|
| 2021-03-31 | $158.00K 10-Q · filed 2022-05-05 |
| 2020-12-31 | $158.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $316.00K 10-Q · filed 2021-11-09 |
| 2020-06-30 | $316.00K 10-Q · filed 2021-08-11 |
| 2020-03-31 | $316.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $316.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $316.00K 10-Q · filed 2019-11-08 |
| 2019-06-30 | $5.32M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $527.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $527.00K 10-K · filed 2020-02-25 |
| 2018-09-30 | $527.00K 10-Q · filed 2018-11-01 |
| 2018-06-30 | $527.00K 10-Q · filed 2018-08-02 |
| 2018-03-31 | $527.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $4.41M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |